Dalian Qin

3.0k total citations · 1 hit paper
93 papers, 2.2k citations indexed

About

Dalian Qin is a scholar working on Molecular Biology, Physiology and Epidemiology. According to data from OpenAlex, Dalian Qin has authored 93 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 22 papers in Physiology and 20 papers in Epidemiology. Recurrent topics in Dalian Qin's work include Autophagy in Disease and Therapy (20 papers), Alzheimer's disease research and treatments (19 papers) and Genetics, Aging, and Longevity in Model Organisms (11 papers). Dalian Qin is often cited by papers focused on Autophagy in Disease and Therapy (20 papers), Alzheimer's disease research and treatments (19 papers) and Genetics, Aging, and Longevity in Model Organisms (11 papers). Dalian Qin collaborates with scholars based in China, Macao and United States. Dalian Qin's co-authors include Jianming Wu, Anguo Wu, Yong Tang, Chong‐Lin Yu, Xiaogang Zhou, Betty Yuen Kwan Law, Lu Yu, Wenqiao Qiu, Rong Pan and Vincent Kam Wai Wong and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, The FASEB Journal and Free Radical Biology and Medicine.

In The Last Decade

Dalian Qin

88 papers receiving 2.2k citations

Hit Papers

Polyphyllin VI Induces Caspase-1-Mediated Pyroptosis via ... 2020 2026 2022 2024 2020 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dalian Qin China 27 1.0k 390 294 251 218 93 2.2k
Lu Yu China 27 898 0.9× 374 1.0× 275 0.9× 480 1.9× 251 1.2× 82 2.1k
Haiyan Lou China 30 1.1k 1.1× 442 1.1× 257 0.9× 485 1.9× 188 0.9× 68 2.6k
Xin Jin China 25 754 0.7× 319 0.8× 178 0.6× 351 1.4× 195 0.9× 69 2.0k
Weizu Li China 31 1.1k 1.1× 353 0.9× 210 0.7× 401 1.6× 311 1.4× 88 2.3k
Chuanbin Yang China 29 972 0.9× 479 1.2× 542 1.8× 188 0.7× 242 1.1× 71 2.3k
Hailian Shi China 29 1.1k 1.1× 233 0.6× 158 0.5× 307 1.2× 264 1.2× 81 2.3k
Md. Jakaria Bangladesh 21 892 0.9× 331 0.8× 117 0.4× 305 1.2× 221 1.0× 66 2.0k
Weiwei Chen China 20 774 0.8× 611 1.6× 181 0.6× 407 1.6× 215 1.0× 73 2.5k
Xiaogang Zhou China 23 846 0.8× 296 0.8× 213 0.7× 164 0.7× 137 0.6× 74 1.8k

Countries citing papers authored by Dalian Qin

Since Specialization
Citations

This map shows the geographic impact of Dalian Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dalian Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dalian Qin more than expected).

Fields of papers citing papers by Dalian Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dalian Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dalian Qin. The network helps show where Dalian Qin may publish in the future.

Co-authorship network of co-authors of Dalian Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Dalian Qin. A scholar is included among the top collaborators of Dalian Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dalian Qin. Dalian Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xiaoqian, Lu Yu, Jianming Wu, et al.. (2025). NAD+ supplementation augments the efficacy of the PARP1 inhibitor PJ34 in a 6-OHDA-induced model of Parkinson’s disease. Genes & Diseases. 13(2). 101783–101783.
2.
Qin, Dalian, Xiaogang Zhou, Lu Yu, et al.. (2025). Prosapogenin CP4 exacerbates mitophagy to induce apoptosis via AMPK-mTOR and PINK1/Parkin pathways in A549 cells. Phytomedicine. 148. 157333–157333. 1 indexed citations
3.
Guo, Minsong, Xiaogang Zhou, Chong‐Lin Yu, et al.. (2025). Ciliatoside A attenuates neuroinflammation in Alzheimer's disease by activating mitophagy and inhibiting NLRP3 inflammasome activation. Phytomedicine. 145. 156928–156928. 2 indexed citations
4.
Zhu, Yunfei, Haijun Fu, Yaping Li, et al.. (2025). Tricin Delays Aging and Enhances Muscle Function via Activating AMPK-Mediated Autophagy in Diverse Model Organisms. Journal of Agricultural and Food Chemistry. 73(17). 10246–10264. 2 indexed citations
5.
Zeng, Juan, Xinxin Tang, Dalian Qin, et al.. (2025). Engineered GLP-1R-targeting nanoplatforms: multimodal therapeutics in human diseases. Journal of Nanobiotechnology. 23(1). 682–682. 1 indexed citations
6.
Wei, Jing, et al.. (2024). Targeting inflammation and gut microbiota with antibacterial therapy: Implications for central nervous system health. Ageing Research Reviews. 102. 102544–102544. 5 indexed citations
7.
Fan, Dongsheng, Minsong Guo, Lu Yu, et al.. (2024). Penthorum chinense Pursh inhibits ferroptosis in cellular and Caenorhabditis elegans models of Alzheimerʼs disease. Phytomedicine. 127. 155463–155463. 13 indexed citations
8.
Dai, Jianghong, et al.. (2024). Mercaptopyrimidine-templated gold nanoclusters for antithrombotic therapy. Journal of Materials Chemistry B. 12(7). 1775–1781. 1 indexed citations
9.
Li, Xiaoqian, Xiaogang Zhou, Lu Yu, et al.. (2024). Hederagenin inhibits mitochondrial damage in Parkinson’s disease via mitophagy induction. Free Radical Biology and Medicine. 224. 740–756. 8 indexed citations
10.
Tang, Xiaoqin, Rui Liao, Xiaogang Zhou, et al.. (2024). Activating SRC/MAPK signaling via 5-HT1A receptor contributes to the effect of vilazodone on improving thrombocytopenia. eLife. 13. 3 indexed citations
11.
Zhou, Xiaogang, Jing Wang, Lu Yu, et al.. (2024). Mitophagy and cGAS–STING crosstalk in neuroinflammation. Acta Pharmaceutica Sinica B. 14(8). 3327–3361. 44 indexed citations
12.
Tang, Yong, et al.. (2023). Next-generation nanomaterials: advancing ocular anti-inflammatory drug therapy. Journal of Nanobiotechnology. 21(1). 282–282. 51 indexed citations
13.
14.
Chi, Feng, Lan Deng, Jianming Wu, et al.. (2023). The Application of Biomaterials in Spinal Cord Injury. International Journal of Molecular Sciences. 24(1). 816–816. 28 indexed citations
15.
Fu, Haijun, Yaping Li, Dalian Qin, et al.. (2023). The Protective Effects of Reineckia carnea Ether Fraction against Alzheimer’s Disease Pathology: An Exploration in Caenorhabditis elegans Models. International Journal of Molecular Sciences. 24(22). 16536–16536. 5 indexed citations
16.
Qin, Dalian, Xiaohui Su, Lu Yu, et al.. (2023). Carpesii fructus extract exhibits neuroprotective effects in cellular and Caenorhabditis elegans models of Parkinson's disease. CNS Neuroscience & Therapeutics. 30(4). e14515–e14515. 10 indexed citations
17.
Wu, Anguo, Jianming Wu, Yong Tang, et al.. (2022). Targeting Nrf2‐Mediated Oxidative Stress Response in Traumatic Brain Injury: Therapeutic Perspectives of Phytochemicals. Oxidative Medicine and Cellular Longevity. 2022(1). 1015791–1015791. 58 indexed citations
18.
Tang, Yong, Changlong He, Lu Yu, et al.. (2022). Ferulic Acid Exerts Neuroprotective Effects via Autophagy Induction in C. elegans and Cellular Models of Parkinson’s Disease. Oxidative Medicine and Cellular Longevity. 2022(1). 3723567–3723567. 43 indexed citations
19.
He, Changlong, Yong Tang, Xue Chen, et al.. (2022). Folium Hibisci Mutabilis extract, a potent autophagy enhancer, exhibits neuroprotective properties in multiple models of neurodegenerative diseases. Phytomedicine. 109. 154548–154548. 13 indexed citations
20.
Li, Xiaoxuan, Xuefei Huang, Dalian Qin, et al.. (2018). Efficacy and Safety of Teneligliptin in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Frontiers in Pharmacology. 9. 449–449. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026